Total Synthesis and Biological Evaluation of 22-Hydroxyacuminatine and the Related Natural Products Norketoyobyrine and Naucleficine
Molecules · 2025
DOI: 10.3390/molecules30122650 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Shohta Mizuno und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, 1 Sanzo, Gakuen-cho, Fukuyama 729-0292, Hiroshima, Japan. Hauptthemen laut MEDLINE: Biological Products, Indolizines, Antineoplastic Agents. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fukuyama University, Fukuyama University Grant for Academic Research Projects.
Abstract (Originalsprache)
Aromathecin compounds—which contain the same indolizine core structure as camptothecin-like compounds—are expected to show anticancer activity. Among them, 22-hydroxyacuminatine—which has a substituent on the E-ring of the pentacyclic scaffold—exhibits topoisomerase 1 inhibitory activity; therefore, the development of efficient methods for its synthesis has been actively pursued. Herein, we report a versatile synthetic methodology for introducing various substituents on the E-ring, leading to the total synthesis of 22-hydroxyacuminatine as a model compound of the aromathecin family. The synthesis comprises the following key steps: the synthesis of an isoquinoline N-oxide via the thermal cyclization of 2-alkynylbenzaldehyde oxime, the subsequent Reissert–Henze-type reaction to yield an isoquinolone, and the construction of the indolizine moiety (CD-ring) through C–N bond formation via the Mitsunobu reaction. Consequently, a pentacyclic benz[6,7]indolizino[1,2-b]quinolin-11(13H)-one framework is obtained. Using this methodology, the total synthesis of the natural products norketoyobyrine and naucleficine and an intermediate of the latter, which are indoloquinolizidine-type alkaloids, was achieved, and their antiproliferative activity against HCT-116 human colon cancer cells and HepG2 human liver cancer cells was assessed. Naucleficine and its intermediate exhibited moderate antiproliferative activity against HCT-116 cells, with IC50 values of 55.58 and 41.40 μM, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, 1 Sanzo, Gakuen-cho, Fukuyama 729-0292, Hiroshima, Japan.
- Faculty of Pharmaceutical Sciences, Yokohama University of Pharmacy, 601 Matano, Totsuka-ku, Yokohama 245-0066, Kanagawa, Japan.
ORCID-Profile: Toshiyuki Hata, Tominari Choshi
Förderung
- Fukuyama University
- Fukuyama University Grant for Academic Research Projects
Zitieren
APA
Mizuno, S., Nishiyama, T., Bessho, H., Nakamura, T., Oe, T., Hayashi, N., Hieda, Y., Motoyashiki, T., Hata, T., Hatae, N., & Choshi, T. (2025). Total Synthesis and Biological Evaluation of 22-Hydroxyacuminatine and the Related Natural Products Norketoyobyrine and Naucleficine. Molecules. https://doi.org/10.3390/molecules30122650
Vancouver
Mizuno S, Nishiyama T, Bessho H, Nakamura T, Oe T, Hayashi N, et al. Total Synthesis and Biological Evaluation of 22-Hydroxyacuminatine and the Related Natural Products Norketoyobyrine and Naucleficine. Molecules. 2025. doi:10.3390/molecules30122650
BibTeX
@article{Mizuno2025,
author = {Mizuno, Shohta and Nishiyama, Takashi and Bessho, Hana and Nakamura, Tetsuya and Oe, Tomoki and Hayashi, Nanako and Hieda, Yuhzo and Motoyashiki, Toshio and Hata, Toshiyuki and Hatae, Noriyuki and Choshi, Tominari},
title = {Total Synthesis and Biological Evaluation of 22-Hydroxyacuminatine and the Related Natural Products Norketoyobyrine and Naucleficine},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30122650}
}
EUVIMED